Back to Search Start Over

Role of mitochondrial calcium uniporter-mediated Ca 2+ and iron accumulation in traumatic brain injury.

Authors :
Zhang L
Wang H
Zhou X
Mao L
Ding K
Hu Z
Source :
Journal of cellular and molecular medicine [J Cell Mol Med] 2019 Apr; Vol. 23 (4), pp. 2995-3009. Date of Electronic Publication: 2019 Feb 12.
Publication Year :
2019

Abstract

Previous studies have suggested that the cellular Ca <superscript>2+</superscript> and iron homeostasis, which can be regulated by mitochondrial calcium uniporter (MCU), is associated with oxidative stress, apoptosis and many neurological diseases. However, little is known about the role of MCU-mediated Ca <superscript>2+</superscript> and iron accumulation in traumatic brain injury (TBI). Under physiological conditions, MCU can be inhibited by ruthenium red (RR) and activated by spermine (Sper). In the present study, we used RR and Sper to reveal the role of MCU in mouse and neuron TBI models. Our results suggested that the Ca <superscript>2+</superscript> and iron concentrations were obviously increased after TBI. In addition, TBI models showed a significant generation of reactive oxygen species (ROS), decrease in adenosine triphosphate (ATP), deformation of mitochondria, up-regulation of deoxyribonucleic acid (DNA) damage and increase in apoptosis. Blockage of MCU by RR prevented Ca <superscript>2+</superscript> and iron accumulation, abated the level of oxidative stress, improved the energy supply, stabilized mitochondria, reduced DNA damage and decreased apoptosis both in vivo and in vitro. Interestingly, Sper did not increase cellular Ca <superscript>2+</superscript> and iron concentrations, but suppressed the Ca <superscript>2+</superscript> and iron accumulation to benefit the mice in vivo. However, Sper had no significant impact on TBI in vitro. Taken together, our data demonstrated for the first time that blockage of MCU-mediated Ca <superscript>2+</superscript> and iron accumulation was essential for TBI. These findings indicated that MCU could be a novel therapeutic target for treating TBI.<br /> (© 2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.)

Details

Language :
English
ISSN :
1582-4934
Volume :
23
Issue :
4
Database :
MEDLINE
Journal :
Journal of cellular and molecular medicine
Publication Type :
Academic Journal
Accession number :
30756474
Full Text :
https://doi.org/10.1111/jcmm.14206